Both HIF3A and CITED4 were hypermethylated and downregulated in the HLRCC tumors consistent with enhancing the HIF1α-driven activation of the HIF pathway. The gene discussed is HIF1A; the disease is hereditary leiomyomatosis and renal cell cancer.